vs

Side-by-side financial comparison of C3.ai, Inc. (AI) and MEDIFAST INC (MED). Click either name above to swap in a different company.

C3.ai, Inc. is the larger business by last-quarter revenue ($75.1M vs $75.1M, roughly 1.0× MEDIFAST INC). On growth, C3.ai, Inc. posted the faster year-over-year revenue change (-20.3% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-46.9M). Over the past eight quarters, C3.ai, Inc.'s revenue compounded faster (-2.1% CAGR vs -34.4%).

C3.ai, Inc. is a leading enterprise artificial intelligence software provider that develops and delivers scalable AI applications, platform tools, and industry-specific solutions for clients across sectors including manufacturing, energy, financial services, healthcare and public sector. Its offerings help organizations optimize operations, reduce costs, mitigate risks, and realize data-driven decision making.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

AI vs MED — Head-to-Head

Bigger by revenue
AI
AI
1.0× larger
AI
$75.1M
$75.1M
MED
Growing faster (revenue YoY)
AI
AI
+16.6% gap
AI
-20.3%
-36.9%
MED
More free cash flow
MED
MED
$40.3M more FCF
MED
$-6.6M
$-46.9M
AI
Faster 2-yr revenue CAGR
AI
AI
Annualised
AI
-2.1%
-34.4%
MED

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AI
AI
MED
MED
Revenue
$75.1M
$75.1M
Net Profit
$-104.7M
Gross Margin
40.4%
69.4%
Operating Margin
-149.2%
-10.4%
Net Margin
-139.3%
Revenue YoY
-20.3%
-36.9%
Net Profit YoY
-58.7%
EPS (diluted)
$-0.75
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AI
AI
MED
MED
Q4 25
$75.1M
$75.1M
Q3 25
$70.3M
$89.4M
Q2 25
$108.7M
$105.6M
Q1 25
$98.8M
$115.7M
Q4 24
$94.3M
$119.0M
Q3 24
$87.2M
$140.2M
Q2 24
$86.6M
$168.6M
Q1 24
$78.4M
$174.7M
Net Profit
AI
AI
MED
MED
Q4 25
$-104.7M
Q3 25
$-116.8M
$-2.3M
Q2 25
$-79.7M
$2.5M
Q1 25
$-80.2M
$-772.0K
Q4 24
$-66.0M
Q3 24
$-62.8M
$1.1M
Q2 24
$-72.9M
$-8.2M
Q1 24
$-72.6M
$8.3M
Gross Margin
AI
AI
MED
MED
Q4 25
40.4%
69.4%
Q3 25
37.6%
69.5%
Q2 25
62.1%
72.6%
Q1 25
59.1%
72.8%
Q4 24
61.3%
74.1%
Q3 24
59.8%
75.4%
Q2 24
59.6%
73.2%
Q1 24
57.8%
72.8%
Operating Margin
AI
AI
MED
MED
Q4 25
-149.2%
-10.4%
Q3 25
-177.7%
-4.6%
Q2 25
-81.8%
-1.0%
Q1 25
-88.7%
-1.1%
Q4 24
-79.8%
0.6%
Q3 24
-83.2%
1.5%
Q2 24
-95.1%
-4.7%
Q1 24
-105.3%
4.5%
Net Margin
AI
AI
MED
MED
Q4 25
-139.3%
Q3 25
-166.2%
-2.5%
Q2 25
-73.3%
2.3%
Q1 25
-81.2%
-0.7%
Q4 24
-69.9%
Q3 24
-72.0%
0.8%
Q2 24
-84.2%
-4.8%
Q1 24
-92.6%
4.8%
EPS (diluted)
AI
AI
MED
MED
Q4 25
$-0.75
$-1.64
Q3 25
$-0.86
$-0.21
Q2 25
$-0.60
$0.22
Q1 25
$-0.62
$-0.07
Q4 24
$-0.52
$0.08
Q3 24
$-0.50
$0.10
Q2 24
$-0.59
$-0.75
Q1 24
$-0.60
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AI
AI
MED
MED
Cash + ST InvestmentsLiquidity on hand
$675.0M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$771.9M
$198.9M
Total Assets
$961.3M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AI
AI
MED
MED
Q4 25
$675.0M
$167.3M
Q3 25
$711.9M
$173.5M
Q2 25
$742.7M
$162.7M
Q1 25
$724.3M
$164.6M
Q4 24
$730.4M
$162.3M
Q3 24
$762.5M
$170.0M
Q2 24
$750.4M
$163.5M
Q1 24
$723.3M
$156.4M
Stockholders' Equity
AI
AI
MED
MED
Q4 25
$771.9M
$198.9M
Q3 25
$798.8M
$214.7M
Q2 25
$838.3M
$216.0M
Q1 25
$860.2M
$211.0M
Q4 24
$859.0M
$210.1M
Q3 24
$874.9M
$207.3M
Q2 24
$873.4M
$205.3M
Q1 24
$898.0M
$211.0M
Total Assets
AI
AI
MED
MED
Q4 25
$961.3M
$248.0M
Q3 25
$968.7M
$268.2M
Q2 25
$1.0B
$269.3M
Q1 25
$1.1B
$280.0M
Q4 24
$1.0B
$284.2M
Q3 24
$1.1B
$291.2M
Q2 24
$1.0B
$293.5M
Q1 24
$1.1B
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AI
AI
MED
MED
Operating Cash FlowLast quarter
$-46.5M
$-5.3M
Free Cash FlowOCF − Capex
$-46.9M
$-6.6M
FCF MarginFCF / Revenue
-62.4%
-8.8%
Capex IntensityCapex / Revenue
0.5%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.2M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AI
AI
MED
MED
Q4 25
$-46.5M
$-5.3M
Q3 25
$-33.5M
$12.1M
Q2 25
$11.3M
$-3.4M
Q1 25
$-22.0M
$3.4M
Q4 24
$-38.7M
$-4.9M
Q3 24
$8.0M
$9.1M
Q2 24
$21.3M
$13.1M
Q1 24
$-39.1M
$7.3M
Free Cash Flow
AI
AI
MED
MED
Q4 25
$-46.9M
$-6.6M
Q3 25
$-34.3M
$10.8M
Q2 25
$10.3M
$-4.8M
Q1 25
$-22.4M
$1.9M
Q4 24
$-39.5M
$-7.2M
Q3 24
$7.1M
$7.7M
Q2 24
$18.8M
$11.1M
Q1 24
$-45.1M
$5.4M
FCF Margin
AI
AI
MED
MED
Q4 25
-62.4%
-8.8%
Q3 25
-48.8%
12.0%
Q2 25
9.5%
-4.5%
Q1 25
-22.7%
1.6%
Q4 24
-41.9%
-6.1%
Q3 24
8.2%
5.5%
Q2 24
21.7%
6.6%
Q1 24
-57.6%
3.1%
Capex Intensity
AI
AI
MED
MED
Q4 25
0.5%
1.8%
Q3 25
1.1%
1.5%
Q2 25
0.9%
1.3%
Q1 25
0.4%
1.3%
Q4 24
0.9%
1.9%
Q3 24
1.1%
1.0%
Q2 24
2.9%
1.1%
Q1 24
7.8%
1.1%
Cash Conversion
AI
AI
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AI
AI

License And Service$70.2M93%
Professional Services$4.9M7%

MED
MED

Segment breakdown not available.

Related Comparisons